Blog - Page 3720 of 5768

ThursdayNov 18, 2010 10:14 am

Adama Technologies Corp (ADAC.OB) Projects Substantial Revenue Growth, Drops Merger Activities to Ensure Profit Retention for Shareholders

Adama Technologies, www.adama-tech.com – developers of the revolutionary MBS (molecular bonding system) technology which is capable of providing a long-term answer to inestimably dangerous heavy metal waste pollution, projected extremely positive 2011 financial growth data today: • Revenue $8M • Gross Profit 40% or roughly $4M • Net Income $3M Projected revenue growth for 2011 is expected to exceed even today’s projections subsequent to pending approval of the MBS technology by Israel’s IEPA, thus securing even more territory for ADAC, which is already developing in Romania and surrounding countries. Adama’s MBS technology can treat all RCRA/UTS-defined (Resource and Recovery Act,…

ThursdayNov 18, 2010 10:10 am

China Kangtai Cactus Biotech Inc. (CKGT.OB) Reports Financial Results for Third Quarter 2010

China Kangtai Cactus Biotech Inc. announced yesterday that its 2010 third quarter revenue increased by 16.3% to $9.5 million from the same period last year. The company also reported a gain in net income, which went up 889% to $8.2 million, or $0.13 per diluted share. China Kangtai Cactus Biotech posted a variety of financial statistics, giving a general overview of its performance. Gross profit margin was 38% compared with 40% in the third quarter of 2009. Income from operations decreased from $3.5 million in 2009 to $3.1 million. Weighted average number of diluted shares outstanding was 21.6 million for…

ThursdayNov 18, 2010 10:05 am

PolyMedix, Inc. (PYMX.OB) Appoints Steffen Helmling as VP of Business Development

Yesterday, PolyMedix, Inc. announced the appointment of Steffen Helmling, Ph.D. as their new Vice President of Business Development. Dr. Helmling will be responsible for new development initiatives, such as partnering and licensing for PolyMedix's products in development. PolyMedix is a biotech company focused on developing new pharmaceuticals for the treatment of infectious diseases and cardiovascular disorders. PolyMedix's lead antibiotic, MX-30063, is in Phase 2 clinical trials, and its lead heptagonist compound, PMX-60056, has completed Phase 1 trials. Their PolyCides products are intended to be used as additives to such items as paints, plastic and textile to create self-sterilizing surfaces. Dr.…

ThursdayNov 18, 2010 9:31 am

Simulated Environment Concepts, Inc. (SMEV.PK) Exceeds Sales Expectations

Simulated Environment Concepts this morning announced that the expected number of sales has been exceeded by some of its distributors. “Sales of the SpaCapsule are steadily increasing,” stated Dr. Ilya Spivak, Marketing Director of Simulated Environment Concepts (SE Concepts) and Co-Inventor of the SpaCapsule. “If distributors continue at this rate, our 4-year agreements could be completed within 3-years.” The company has signed several multi-year, multi-million dollar manufacturing deals with international distributors this past year; estimating sales of nearly 600 units. Distribution companies like Zen & O and I. SEPTA Co., LTD are taking full advantage of SE Concepts' recent FDA…

ThursdayNov 18, 2010 9:17 am

Daulton Capital Corp. (DUCP.OB) Provides Shareholder Update; Recognizes Rising Gold Prices

Daulton Capital Corp., a natural resource finance company focused on precious & base metal developments and oil & gas properties, was pleased to provide the investment community with an update regarding gold exploration and development underway in the Yukon. In the Yukon Gold region close to Daulton's Hunker Property (Crown Jewel Claims), exploration targets are being identified by many other companies where gold-bearing veins have hosted historic mining operations. The company pointed out Northern Tiger Resources' recent announcement of a significant gold discovery at 3Ace Property, in the Yukon with 14.8 g/t gold over 10.9 metres, including 145.2 g/t over…

WednesdayNov 17, 2010 4:34 pm

Consorteum Holdings, Inc. (CSRH.OB) Firmly Established for Further Success

Consorteum Holdings Inc. has strategically expanded its operations to cover almost every aspect of card, payment, and transaction processing. The primary focus of the company's solutions has always been to facilitate the transfer of financial or informational value in the most cost effective, creative, and user friendly way possible, making it easier on businesses while making it attractive to customers. Here is a sample of the markets currently being addressed by Consorteum to give an idea of their range of service. • Unbanked/Underbanked – It is estimated as much as 30% of the work force (some 130 million in North…

WednesdayNov 17, 2010 3:26 pm

PositiveID Corp. (PSID) Launches “The Wireless Body™” Embedded Bio-Sensor System for Diabetes Applications

PositiveID, www.positiveidcorp.com – developers of implantable RFID diagnostic/identification technology and disease management tools for the healthcare industry, reported the launch of its The Wireless Body™ system at the ID WORLD International Congress in Milan. The Wireless Body system was designed to be a fully integrated, smart health communication system for diabetics, allowing for real-time management capabilities, but the system also has tremendous future potential as a management platform for other diseases. Unprecedented wireless access to the patient’s vitals and data means that The Wireless Body constitutes a new paradigm in disease management systems. The age of personalized medicine moves ever…

WednesdayNov 17, 2010 3:20 pm

Access Pharmaceuticals, Inc. (ACCP.OB) Presenting Posters at the Innovations in Cancer Prevention and Research Conference

Access Pharmaceuticals, Inc. will be displaying posters on its novel developments in drug delivery platforms for cancer therapy this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX. The Inaugural Conference is being held November 17-19, 2010 and is hosted by the rapidly-growing Cancer Prevention and Research Institute of Texas whose mission is to “create and support infrastructure in Texas that accelerates the movement of new cancer drugs, diagnostics, and therapies from the laboratory to the patient.” Access Pharmaceuticals will be presenting two posters at the event. Poster “Vitamin B-12 Nanoparticles…

WednesdayNov 17, 2010 3:16 pm

China TMK Battery Systems Inc. (DFEL) Reports Third Quarter 2010 Results

China TMK Battery Systems Inc. reported large year over year increases in revenue and net income as the company benefited from strong demand for its products. China TMK Battery Systems Inc. reported sales of $16.5 million in the quarter ending 9/30/2010, a 27% increase from the $13 million reported in the same quarter of 2009. China TMK Battery Systems Inc. reported net income of $3.1 million, or $0.08 per diluted share, in the third quarter of 2010. The company earned net income of $1.1 million, or $0.08 per diluted share, in the third quarter of 2009. The management of China…

WednesdayNov 17, 2010 3:12 pm

Intellipharmaceutics International, Inc. (IPCI) Appoints New Chief Financial Officer

On November 29, 2010, Intellipharmaceutics International, Inc. will have newly-appointed Shameze Rampertab stepping-in to serve as the company’s new Chief Financial Officer, replacing the recently resigned Graham Neil. Mr. Neil recently stepped-down to pursue other business opportunities. Mr. Rampertab will be bringing a highly-relevant skill set with him to the Intellipharmaceutics’ team. A chartered accountant for nearly twenty years, he has senior-level executive experience in many aspects of biotechnology and related finance fields, including licensing and royalty agreements, through his previous positions at companies such as Drug Royalty Corporation, where he served as Director as well as Finance and Secretary-Treasurer.…

Site Search

Company Search